A carregar...

Access to orphan drugs despite poor quality of clinical evidence

AIM: We analysed the Belgian reimbursement decisions of orphan drugs as compared with those of innovative drugs for more common but equally severe diseases, with special emphasis on the quality of clinical evidence. METHODS: Using the National Health Insurance Agency administrative database, we eval...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dupont, Alain G, Van Wilder, Philippe B
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Inc 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3080635/
https://ncbi.nlm.nih.gov/pubmed/21395641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2010.03877.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!